Sale!

CRYAA Gene Cataract Autosomal Recessive Congenital Type 1 Genetic Test

Original price was: $700.Current price is: $500.

-29%

The CRYAA Gene Cataract Autosomal Recessive Congenital Type 1 NGS Genetic DNA Test is a cutting-edge diagnostic tool that identifies mutations in the CRYAA gene responsible for congenital cataracts. This comprehensive test utilizes Next-Generation Sequencing (NGS) technology to provide accurate detection of autosomal recessive genetic disorders affecting eye development. Priced at $500 USD (regularly $700), the test is essential for families with a history of congenital cataracts, infants showing early vision problems, or couples planning pregnancy with known genetic risks. Results are available within 3-4 weeks and require only a simple blood sample or DNA extraction. Early detection through this test enables proactive management and treatment planning for optimal visual outcomes.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

CRYAA Gene Cataract Autosomal Recessive Congenital Type 1 NGS Genetic DNA Test

Comprehensive Genetic Testing for Congenital Cataracts

The CRYAA Gene Cataract Autosomal Recessive Congenital Type 1 NGS Genetic DNA Test represents a breakthrough in ophthalmic genetic diagnostics, offering families unprecedented insight into inherited eye conditions. This advanced testing methodology provides crucial information for early intervention and personalized treatment strategies for congenital cataracts, a condition affecting approximately 1 in 5,000 newborns worldwide.

What Does This Test Measure?

Our specialized genetic test focuses specifically on detecting mutations in the CRYAA (Crystallin Alpha A) gene, which plays a critical role in maintaining lens transparency and proper eye development. The test utilizes Next-Generation Sequencing technology to analyze:

  • Point mutations in the CRYAA gene coding regions
  • Small insertions and deletions affecting gene function
  • Genetic variations associated with autosomal recessive inheritance patterns
  • Pathogenic variants linked to congenital cataract development

Who Should Consider This Test?

This genetic test is particularly recommended for individuals and families experiencing:

  • Newborns or infants with unexplained vision impairment or cloudy lenses
  • Family history of congenital cataracts across multiple generations
  • Parents planning pregnancy with known genetic cataract predisposition
  • Children diagnosed with bilateral cataracts without clear environmental causes
  • Individuals with early-onset cataracts before age 40
  • Couples seeking preconception genetic screening

Clinical Symptoms and Indications

Early recognition of CRYAA-related congenital cataracts is crucial for optimal outcomes. Watch for these symptoms:

  • Cloudy or white appearance in the pupil area
  • Poor visual tracking in infants
  • Nystagmus (involuntary eye movements)
  • Photophobia (light sensitivity)
  • Strabismus (crossed eyes)
  • Delayed visual development milestones

Benefits of CRYAA Genetic Testing

Choosing our comprehensive genetic analysis provides numerous advantages for patients and families:

  • Early Diagnosis: Enables prompt intervention during critical developmental periods
  • Personalized Treatment: Guides ophthalmologists in creating targeted management plans
  • Family Planning: Provides crucial information for genetic counseling and reproductive decisions
  • Proactive Monitoring: Allows for regular screening of at-risk family members
  • Peace of Mind: Reduces uncertainty and empowers informed healthcare decisions

Understanding Your Test Results

Our comprehensive genetic counseling services help you interpret your results accurately:

  • Positive Result: Indicates presence of CRYAA gene mutations; requires consultation with ophthalmology and genetics specialists
  • Negative Result: Suggests no detected mutations; however, regular eye examinations remain important
  • Variant of Uncertain Significance: Requires additional family studies and ongoing research correlation
  • Carrier Status: Important information for family planning and genetic counseling

Test Pricing and Details

Test Component Details
Test Name CRYAA Gene Cataract Autosomal Recessive Congenital Type 1 NGS Genetic DNA Test
Discount Price $500 USD
Regular Price $700 USD
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card
Testing Method Next-Generation Sequencing (NGS) Technology

Pre-Test Requirements

To ensure optimal testing accuracy and comprehensive care:

  • Complete clinical history documentation
  • Genetic counseling session with certified genetic counselor
  • Detailed pedigree chart of family members affected by congenital cataracts
  • Ophthalmology consultation and examination

Nationwide Accessibility

We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more. Our network of certified genetic counselors and ophthalmology specialists ensures comprehensive care regardless of your location.

Take Control of Your Genetic Health Today

Don’t let uncertainty about congenital cataracts affect your family’s future. Our CRYAA Gene Cataract Test provides the clarity and confidence you need for informed healthcare decisions. With our limited-time discount pricing and comprehensive genetic counseling services, now is the perfect time to take proactive steps toward understanding your genetic health.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your genetic counseling session and book your test. Our dedicated team is ready to answer your questions and guide you through the testing process with compassion and expertise.